Skip to main content
Top
Published in: Current Allergy and Asthma Reports 4/2012

01-08-2012 | ALLERGIC DERMATOSIS AND URTICARIA (J RING, SECTION EDITOR)

Physical Urticaria

Authors: Marina Abajian, Agnieszka Młynek, Marcus Maurer

Published in: Current Allergy and Asthma Reports | Issue 4/2012

Login to get access

Abstract

The physical urticarias are a heterogeneous subgroup of chronic urticarias in which wheals can be reproducibly induced by different specific physical stimuli such as cold, heat, pressure, vibration, or sunlight. Physical urticarias comprise up to 25 % of chronic urticarias and occur more frequently in young adults. Symptoms, i.e. wheal and flare responses or angioedema, are usually limited to the skin areas exposed to the eliciting stimulus. However, generalised urticaria with variable extracutaneous manifestations can also occur. Some patients may also present with more than one physical urticaria. Skin lesions in physical urticaria result from mast cell activation and mediator release. The mechanisms by which physical stimuli activate skin mast cells are not fully understood. Because of this, trigger avoidance and symptomatic treatment are key therapeutic concepts for physical urticarias. Identification of the inducing physical trigger, including its individual thresholds, is necessary for an effective therapy. Here, we have summarized clinical features, diagnostic workup and therapy options for physical urticarias.
Literature
1.
go back to reference Kontou-Fili K, Borici-Mazi R, Kapp A, et al. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy. 1997;52:504–13.PubMedCrossRef Kontou-Fili K, Borici-Mazi R, Kapp A, et al. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy. 1997;52:504–13.PubMedCrossRef
2.
go back to reference Torchia D, Francalanci S, Bellandi S, et al. Multiple physical urticarias. Postgrad Med J. 2008;84:e1–2.PubMedCrossRef Torchia D, Francalanci S, Bellandi S, et al. Multiple physical urticarias. Postgrad Med J. 2008;84:e1–2.PubMedCrossRef
3.
go back to reference •• Magerl M, Borzova E, Gimenez-Arnau A, et al. The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy. 2009;64:1715–21. This guideline describes diagnostic approaches for all inducible urticarias.PubMedCrossRef •• Magerl M, Borzova E, Gimenez-Arnau A, et al. The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy. 2009;64:1715–21. This guideline describes diagnostic approaches for all inducible urticarias.PubMedCrossRef
4.
go back to reference •• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43. In this guideline, treatment options for urticaria are evaluated and recommendations for management are provided.PubMedCrossRef •• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43. In this guideline, treatment options for urticaria are evaluated and recommendations for management are provided.PubMedCrossRef
5.
go back to reference Silpa-archa N, Kulthanan K. Pinkaew S Physical urticaria: prevalence, type and natural course in a tropical country. J Eur Acad Dermatol Venereol: JEADV. 2011;25:1194–9.PubMedCrossRef Silpa-archa N, Kulthanan K. Pinkaew S Physical urticaria: prevalence, type and natural course in a tropical country. J Eur Acad Dermatol Venereol: JEADV. 2011;25:1194–9.PubMedCrossRef
6.
go back to reference Taskapan O. Harmanyeri Y Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol: JEADV. 2006;20:58–62.PubMedCrossRef Taskapan O. Harmanyeri Y Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol: JEADV. 2006;20:58–62.PubMedCrossRef
7.
go back to reference Zuberbier T. Maurer M Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol. 2007;87:196–205.PubMed Zuberbier T. Maurer M Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol. 2007;87:196–205.PubMed
8.
go back to reference Herman-Kideckel SM, Cadesky K, Sussman D, et al. Association of dermographic urticaria with the use of progesterone in cottonseed oil. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2011;106:439–40.CrossRef Herman-Kideckel SM, Cadesky K, Sussman D, et al. Association of dermographic urticaria with the use of progesterone in cottonseed oil. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2011;106:439–40.CrossRef
9.
go back to reference Adcock BB, Hornsby LB. Jenkins K Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract/Am Board Fam Pract. 2001;14:148–51. Adcock BB, Hornsby LB. Jenkins K Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract/Am Board Fam Pract. 2001;14:148–51.
10.
go back to reference Ortonne JP. Urticaria and its subtypes: the role of second-generation antihistamines. Eur J Intern Med. 2012;23:26–30.PubMedCrossRef Ortonne JP. Urticaria and its subtypes: the role of second-generation antihistamines. Eur J Intern Med. 2012;23:26–30.PubMedCrossRef
11.
go back to reference • Toda S, Takahagi S, Mihara S, et al. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin. Allergol Int: Off J Jpn Soc Allergol. 2011;60:547–50. First report about the effects of ciclosporin in antihistamine-resistant urticaria factitia. • Toda S, Takahagi S, Mihara S, et al. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin. Allergol Int: Off J Jpn Soc Allergol. 2011;60:547–50. First report about the effects of ciclosporin in antihistamine-resistant urticaria factitia.
12.
go back to reference • Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154:177–80. This is the first case series on successful treatment of physical urticaria with omalizumab.PubMedCrossRef • Metz M, Altrichter S, Ardelean E, et al. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol. 2011;154:177–80. This is the first case series on successful treatment of physical urticaria with omalizumab.PubMedCrossRef
13.
go back to reference • Borzova E, Rutherford A, Konstantinou GN, et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. J Am Acad Dermatol. 2008;59:752–7. Report of UVB-therapy in urticaria factitia and its beneficial effect on itch.PubMedCrossRef • Borzova E, Rutherford A, Konstantinou GN, et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. J Am Acad Dermatol. 2008;59:752–7. Report of UVB-therapy in urticaria factitia and its beneficial effect on itch.PubMedCrossRef
14.
go back to reference Cassano N, Mastrandrea V, Vestita M, et al. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther. 2009;22 Suppl 1:S22–26.PubMedCrossRef Cassano N, Mastrandrea V, Vestita M, et al. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther. 2009;22 Suppl 1:S22–26.PubMedCrossRef
15.
go back to reference Nettis E, Colanardi MC, Soccio AL, et al. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2006;155:1279–82.PubMedCrossRef Nettis E, Colanardi MC, Soccio AL, et al. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study. Br J Dermatol. 2006;155:1279–82.PubMedCrossRef
16.
go back to reference • Grundmann SA, Kiefer S, Luger TA, et al. Delayed pressure urticaria - dapsone heading for first-line therapy? Journal der Deutschen Dermatologischen Gesellschaft. J Ger Soc Dermatol: JDDG. 2011;9:908–12. This study describes benefits of dapson therapy in patients with antihistamine-resistant delayed pressure urticaria. • Grundmann SA, Kiefer S, Luger TA, et al. Delayed pressure urticaria - dapsone heading for first-line therapy? Journal der Deutschen Dermatologischen Gesellschaft. J Ger Soc Dermatol: JDDG. 2011;9:908–12. This study describes benefits of dapson therapy in patients with antihistamine-resistant delayed pressure urticaria.
17.
go back to reference • Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy. 2010;65:138–9. First report on succesful treatment of delayed pressure urticaria with omalizumab.PubMedCrossRef • Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy. 2010;65:138–9. First report on succesful treatment of delayed pressure urticaria with omalizumab.PubMedCrossRef
18.
go back to reference Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417–23.PubMedCrossRef Wanderer AA, Grandel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78:417–23.PubMedCrossRef
19.
go back to reference Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113:e313–317.PubMedCrossRef Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113:e313–317.PubMedCrossRef
20.
go back to reference Neittaanmaki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636–44.PubMedCrossRef Neittaanmaki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13:636–44.PubMedCrossRef
21.
go back to reference Katsarou-Katsari A, Makris M, Lagogianni E, et al. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol: JEADV. 2008;22:1405–11.PubMedCrossRef Katsarou-Katsari A, Makris M, Lagogianni E, et al. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol: JEADV. 2008;22:1405–11.PubMedCrossRef
22.
go back to reference Moller A, Henning M, Zuberbier T, et al. [Epidemiology and clinical aspects of cold urticaria]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1996; 47:510–514. Moller A, Henning M, Zuberbier T, et al. [Epidemiology and clinical aspects of cold urticaria]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1996; 47:510–514.
23.
go back to reference Koeppel MC, Bertrand S, Abitan R, et al. [Urticaria caused by cold. 104 cases]. Annales de dermatologie et de venereologie. 1996;123:627–632. Koeppel MC, Bertrand S, Abitan R, et al. [Urticaria caused by cold. 104 cases]. Annales de dermatologie et de venereologie. 1996;123:627–632.
24.
go back to reference Nakamura Y, Kambe N, Saito M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med. 2009;206:1037–46.PubMedCrossRef Nakamura Y, Kambe N, Saito M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med. 2009;206:1037–46.PubMedCrossRef
25.
go back to reference Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Eng J Med. 2009;360:2416–25.CrossRef Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Eng J Med. 2009;360:2416–25.CrossRef
26.
go back to reference Wasserman SI. Ginsberg MH Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. J Allergy Clin Immunol. 1984;74:275–9.PubMedCrossRef Wasserman SI. Ginsberg MH Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. J Allergy Clin Immunol. 1984;74:275–9.PubMedCrossRef
27.
go back to reference Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213–7.PubMedCrossRef Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213–7.PubMedCrossRef
28.
go back to reference Kaplan AP, Garofalo J, Sigler R, et al. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Eng J Med. 1981;305:1074–7.CrossRef Kaplan AP, Garofalo J, Sigler R, et al. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Eng J Med. 1981;305:1074–7.CrossRef
29.
go back to reference Mathelier-Fusade P, Aissaoui M, Bakhos D, et al. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134:106–7.PubMedCrossRef Mathelier-Fusade P, Aissaoui M, Bakhos D, et al. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134:106–7.PubMedCrossRef
30.
go back to reference Siebenhaar F, Staubach P, Metz M, et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol. 2004;114:1224–5.PubMedCrossRef Siebenhaar F, Staubach P, Metz M, et al. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol. 2004;114:1224–5.PubMedCrossRef
31.
go back to reference •• Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162:198–200. This study shows the relevance of threshold testing in cold contact urticaria for assessing disease activity and efficacy of therapeutic measures.PubMedCrossRef •• Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162:198–200. This study shows the relevance of threshold testing in cold contact urticaria for assessing disease activity and efficacy of therapeutic measures.PubMedCrossRef
32.
go back to reference Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review. J Am Acad Dermatol. 2003;48:409–16.PubMedCrossRef Kozel MM, Bossuyt PM, Mekkes JR, et al. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: A systematic review. J Am Acad Dermatol. 2003;48:409–16.PubMedCrossRef
33.
go back to reference Krause K, Zuberbier T. Maurer M Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010;10:243–9.PubMedCrossRef Krause K, Zuberbier T. Maurer M Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010;10:243–9.PubMedCrossRef
34.
go back to reference Weinstein ME, Wolff AH. Bielory L Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:518–22.CrossRef Weinstein ME, Wolff AH. Bielory L Efficacy and tolerability of second- and third-generation antihistamines in the treatment of acquired cold urticaria: a meta-analysis. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:518–22.CrossRef
35.
go back to reference Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672–9.PubMedCrossRef Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123:672–9.PubMedCrossRef
36.
go back to reference Magerl M, Schmolke J, Siebenhaar F, et al. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy. 2007;62:1465–8.PubMedCrossRef Magerl M, Schmolke J, Siebenhaar F, et al. Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy. 2007;62:1465–8.PubMedCrossRef
37.
go back to reference Metz M, Scholz E, Ferran M, et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:86–92.CrossRef Metz M, Scholz E, Ferran M, et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann AllergyAsthma Immunol: Off Publ Am Coll Allergy Asthma Immunol. 2010;104:86–92.CrossRef
38.
go back to reference •• Magerl M, Pisarevskaja D, Staubach P, et al. Critical temperature threshold measurement for cold urticaria: a randomised controlled trial of H1-antihistamine up-dosing. Br J Dermatol. 2012. This clinical trial shows the safety and efficacy of up-dosing of non-sedating antihistamines in cold contact urticaria. •• Magerl M, Pisarevskaja D, Staubach P, et al. Critical temperature threshold measurement for cold urticaria: a randomised controlled trial of H1-antihistamine up-dosing. Br J Dermatol. 2012. This clinical trial shows the safety and efficacy of up-dosing of non-sedating antihistamines in cold contact urticaria.
39.
go back to reference Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415–8.PubMedCrossRef Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415–8.PubMedCrossRef
40.
go back to reference • Gualdi G, Monari P, Rossi M, et al. Successful treatment of systemic cold contact urticaria with Etanercept in a patient with psoriasis. Br J Dermatol. 2011. This is the first case report regarding the efficacy of Etanercept in cold contact urticaria. • Gualdi G, Monari P, Rossi M, et al. Successful treatment of systemic cold contact urticaria with Etanercept in a patient with psoriasis. Br J Dermatol. 2011. This is the first case report regarding the efficacy of Etanercept in cold contact urticaria.
41.
go back to reference • Bodar EJ, Simon A, de Visser M, et al. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med. 2009;67:302–5. This is the first case report, about the efficacy of an IL-1 receptor antagonist in cold contact urticaria.PubMed • Bodar EJ, Simon A, de Visser M, et al. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med. 2009;67:302–5. This is the first case report, about the efficacy of an IL-1 receptor antagonist in cold contact urticaria.PubMed
42.
go back to reference Black AK, Sibbald RG. Greaves MW Cold urticaria treated by induction of tolerance. Lancet. 1979;2:964.PubMedCrossRef Black AK, Sibbald RG. Greaves MW Cold urticaria treated by induction of tolerance. Lancet. 1979;2:964.PubMedCrossRef
43.
go back to reference von Mackensen YA. Sticherling M Cold urticaria: tolerance induction with cold baths. Br J Dermatol. 2007;157:835–6.CrossRef von Mackensen YA. Sticherling M Cold urticaria: tolerance induction with cold baths. Br J Dermatol. 2007;157:835–6.CrossRef
44.
go back to reference Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417–26.PubMedCrossRef Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417–26.PubMedCrossRef
46.
go back to reference Bullerkotte U, Wieczorek D, Kapp A, et al. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010;65:931–2.PubMedCrossRef Bullerkotte U, Wieczorek D, Kapp A, et al. Effective treatment of refractory severe heat urticaria with omalizumab. Allergy. 2010;65:931–2.PubMedCrossRef
47.
go back to reference Beattie PE, Dawe RS, Ibbotson SH, et al. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol. 2003;139:1149–54.PubMedCrossRef Beattie PE, Dawe RS, Ibbotson SH, et al. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol. 2003;139:1149–54.PubMedCrossRef
48.
go back to reference Monfrecola G, Masturzo E, Riccardo AM, et al. Solar urticaria: a report on 57 cases. A J Contact Dermatitis: Off J Am Contact Dermatitis Soc. 2000;11:89–94.CrossRef Monfrecola G, Masturzo E, Riccardo AM, et al. Solar urticaria: a report on 57 cases. A J Contact Dermatitis: Off J Am Contact Dermatitis Soc. 2000;11:89–94.CrossRef
49.
50.
go back to reference Monfrecola G, Nappa P. Pini D Solar urticaria with delayed onset: a case report. Photodermatol. 1988;5:103–4.PubMed Monfrecola G, Nappa P. Pini D Solar urticaria with delayed onset: a case report. Photodermatol. 1988;5:103–4.PubMed
51.
52.
go back to reference Torinuki W. Two patients with solar urticaria manifesting pruritic erythema. J Dermatol. 1992;19:635–7.PubMed Torinuki W. Two patients with solar urticaria manifesting pruritic erythema. J Dermatol. 1992;19:635–7.PubMed
53.
54.
go back to reference Esdaile B, Grabczynska S. George S Solar urticaria confined to areas of bruising. Photodermatol Photoimmunol Photomed. 2010;26:211–2.PubMedCrossRef Esdaile B, Grabczynska S. George S Solar urticaria confined to areas of bruising. Photodermatol Photoimmunol Photomed. 2010;26:211–2.PubMedCrossRef
55.
go back to reference Beissert S, Stander H. Schwarz T UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030–2.PubMedCrossRef Beissert S, Stander H. Schwarz T UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol. 2000;42:1030–2.PubMedCrossRef
56.
go back to reference Calzavara-Pinton P, Zane C, Rossi M, et al. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2011. Calzavara-Pinton P, Zane C, Rossi M, et al. Narrowband ultraviolet B phototherapy is a suitable treatment option for solar urticaria. J Am Acad Dermatol. 2011.
57.
go back to reference Guzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563–5.PubMedCrossRef Guzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563–5.PubMedCrossRef
58.
go back to reference Waibel KH, Reese DA, Hamilton RG, et al. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2010;125:490–1.PubMedCrossRef Waibel KH, Reese DA, Hamilton RG, et al. Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol. 2010;125:490–1.PubMedCrossRef
59.
go back to reference Duchini G, Baumler W, Bircher AJ, et al. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed. 2011;27:336–7.PubMedCrossRef Duchini G, Baumler W, Bircher AJ, et al. Failure of omalizumab (Xolair(R)) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed. 2011;27:336–7.PubMedCrossRef
60.
go back to reference Llamas-Velasco M, Argila DD, Eguren C, et al. Solar urticaria unresponsive to intravenous immunoglobulins. Photodermatol Photoimmunol Photomed. 2011;27:53–4.PubMedCrossRef Llamas-Velasco M, Argila DD, Eguren C, et al. Solar urticaria unresponsive to intravenous immunoglobulins. Photodermatol Photoimmunol Photomed. 2011;27:53–4.PubMedCrossRef
61.
go back to reference Hughes R, Cusack C, Murphy GM, et al. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol. 2009;34:e660–662.PubMedCrossRef Hughes R, Cusack C, Murphy GM, et al. Solar urticaria successfully treated with intravenous immunoglobulin. Clin Exp Dermatol. 2009;34:e660–662.PubMedCrossRef
62.
go back to reference Correia I, Silva J, Filipe P, et al. Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed. 2008;24:330–1.PubMedCrossRef Correia I, Silva J, Filipe P, et al. Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report. Photodermatol Photoimmunol Photomed. 2008;24:330–1.PubMedCrossRef
63.
go back to reference • Haylett AK, Nie Z, Brownrigg M, et al. Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH. Br J Dermatol. 2011;164:407–14. This study demonstrates the efficacy of a single-dose α-MSH analogue implant in the prevention of solar urticaria symptoms.PubMedCrossRef • Haylett AK, Nie Z, Brownrigg M, et al. Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH. Br J Dermatol. 2011;164:407–14. This study demonstrates the efficacy of a single-dose α-MSH analogue implant in the prevention of solar urticaria symptoms.PubMedCrossRef
64.
go back to reference Mathelier-Fusade P, Vermeulen C. Leynadier F [Vibratory angioedema]. Ann Dermatol Venereol. 2001;128:750–2.PubMed Mathelier-Fusade P, Vermeulen C. Leynadier F [Vibratory angioedema]. Ann Dermatol Venereol. 2001;128:750–2.PubMed
Metadata
Title
Physical Urticaria
Authors
Marina Abajian
Agnieszka Młynek
Marcus Maurer
Publication date
01-08-2012
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 4/2012
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-012-0269-0

Other articles of this Issue 4/2012

Current Allergy and Asthma Reports 4/2012 Go to the issue

FOOD ALLERGY (D ATKINS, SECTION EDITOR)

Does Early Feeding Promote Development of Oral Tolerance?

ALLERGIC DERMATOSIS AND URTICARIA (J RING, SECTION EDITOR)

Current Management Options for Hereditary Angioedema

FOOD ALLERGY (D ATKINS, SECTION EDITOR)

Sesame Seed Food Allergy

ALLERGIC DERMATOSIS AND URTICARIA (J RING, SECTION EDITOR)

Chronic Urticaria

FOOD ALLERGY (D ATKINS, SECTION EDITOR)

Addressing Food Allergy Issues Within Child Care Centers

ALLERGIC DERMATOSIS AND URTICARIA (J RING, SECTION EDITOR)

Biologic Agents in the Treatment of Urticaria